Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1671 1672
This examiner grants 29% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17925920 | CORONAVIRUS ANTIGEN COMPOSITIONS AND THEIR USES | Final Rejection | Flagship Pioneering Innovations VI, LLC |
| 17713382 | METHODS FOR TREATING COVID-19 BASED ON INDIVIDUAL GENOMIC PROFILES | Non-Final OA | University of South Florida |
| 17631439 | TARGETED EXOSOME BASED ON RBD REGION OF SARS-COV-2 S PROTEIN AND PREPARATION METHOD THEREOF | Non-Final OA | SOOCHOW UNIVERSITY |
| 17905614 | VACCINES AGAINST SARS-COV-2 AND OTHER CORONAVIRUSES | Final Rejection | The Government of the United States, as Represented by the Secretary of the Army |
| 17594349 | A METHOD OF IDENTIFYING A FLAVIVIRUS INFECTION, AND RELATED PEPTIDES, KITS AND COMPOSITIONS | Non-Final OA | Agency for Science, Technology and Research |
| 18015918 | A SIMPLE METHOD FOR COLLECTING A SAMPLE OF A MUCOSAL FLUID ADHERED TO THE MUCOSAL SURFACE OF THE NASAL CAVITY AND A TEST KIT FOR DETECTING AN ANALYTE IN THE SAMPLE | Final Rejection | Denka Company Limited |
| 17919096 | ADENOVIRUS IMMUNOASSAY METHOD AND IMMUNOASSAY INSTRUMENT | Non-Final OA | DENKA COMPANY LIMITED |
| 17996680 | DEVICE AND METHOD FOR RAPID DETECTION OF VIRUSES | Non-Final OA | NANOSE MEDICAL LTD |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy